
Vect Horus
Biotechnology, 51st BLVD, MARSEILLE, Colorado, 80011, United States, 11-50 Employees
Who is VECT-HORUS
VECT-HORUS, Breaking barriers Vect-Horus designs and develops vectors that facilitate targeting and delivery of therapeutic or imaging agents to organs, including the brain and tumours. V...
Read More

-
Headquarters: 51st BLVD, MARSEILLE , Colorado, 80011, United States
-
Date Founded: 2005
-
Employees: 11-50
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2836
|
NAICS Code: 541714 |
Show More
Does something look wrong? Fix it. | View contact records from VECT-HORUS
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Vect-Horus
Answer: Vect-Horus's headquarters are located at 51st BLVD, MARSEILLE, Colorado, 80011, United States
Answer: Vect-Horus's official website is https://vect-horus.com
Answer: Vect-Horus's revenue is $1 Million to $5 Million
Answer: Vect-Horus's SIC: 2836
Answer: Vect-Horus's NAICS: 541714
Answer: Vect-Horus has 11-50 employees
Answer: Vect-Horus is in Biotechnology
Answer: Vect-Horus contact info: Phone number: Website: https://vect-horus.com
Answer: VECT-HORUS, Breaking barriers Vect-Horus designs and develops vectors that facilitate targeting and delivery of therapeutic or imaging agents to organs, including the brain and tumours. Vect-Horus combines these different agents to its vectors that specifically target various receptors, allowing these agents to cross natural barriers (first and foremost the blood-brain-barrier) which limit access of therapeutic or imaging agents to their targets. The proof of concept of the technology has already been established in animal models using different vectorized molecules. Vect-Horus endorces a mixed business model, based on its proprietary VECTrans technology, both to make its technology platform available to pharmaceutical and biotechnology company partners and to develop an internal pipeline of products. Created in 2005, Vect-Horus is a spin-off of the Institute for Neurophysiopathology (INP, UMR7051, CNRS and Aix Marseille University), headed by Dr Michel Khrestchatisky, co-founder. Based in Marseille, France, the company has 35 employees, mostly in R&D, and develops academic collaborations with the CNRS, INSERM and CEA as well as industrial partnerships.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Sign in to CIENCE GO Data to uncover contact details
Free credits every month